BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23674942)

  • 1. Nocturnal temazepam in the treatment of narcolepsy.
    Kansagra S; Walter R; Vaughn B
    J Clin Sleep Med; 2013 May; 9(5):499-500. PubMed ID: 23674942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group
    J Clin Sleep Med; 2005 Oct; 1(4):391-7. PubMed ID: 17564408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate.
    Murali H; Kotagal S
    Sleep; 2006 Aug; 29(8):1025-9. PubMed ID: 16944670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary.
    Rosenberg R; Braceras R; Macfadden W; Candler S; Black J; Ruoff C
    Neurol Ther; 2023 Dec; 12(6):1805-1820. PubMed ID: 37755650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy.
    Mamelak M; Black J; Montplaisir J; Ristanovic R
    Sleep; 2004 Nov; 27(7):1327-34. PubMed ID: 15586785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
    Mansukhani MP; Kotagal S
    Sleep Med; 2012 Jun; 13(6):606-10. PubMed ID: 22445591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study.
    Lecendreux M; Poli F; Oudiette D; Benazzouz F; Donjacour CE; Franceschini C; Finotti E; Pizza F; Bruni O; Plazzi G
    Sleep; 2012 May; 35(5):709-11. PubMed ID: 22547897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy.
    Bogan RK; Roth T; Schwartz J; Miloslavsky M
    J Clin Sleep Med; 2015 Apr; 11(4):427-32. PubMed ID: 25580605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of sodium oxybate as a treatment option for narcolepsy.
    Abad VC
    Expert Opin Pharmacother; 2019 Jul; 20(10):1189-1199. PubMed ID: 31136215
    [No Abstract]   [Full Text] [Related]  

  • 10. Levothyroxine improves subjective sleepiness in a euthyroid patient with narcolepsy without cataplexy.
    Sobol DL; Spector AR
    J Clin Sleep Med; 2014 Nov; 10(11):1231-2. PubMed ID: 25325591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
    Huang YS; Guilleminault C
    Pediatr Neurol; 2009 Jul; 41(1):9-16. PubMed ID: 19520267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J; Houghton WC
    Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy.
    Sleep; 2003 Feb; 26(1):31-5. PubMed ID: 12627729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Excessive Daytime Sleepiness in Narcolepsy With Baclofen.
    Morse AM; Kelly-Pieper K; Kothare SV
    Pediatr Neurol; 2019 Apr; 93():39-42. PubMed ID: 30595352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J; Swick T; Bogan R; Lai C; Carter LP
    Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EFNS guidelines on management of narcolepsy.
    Billiard M; Bassetti C; Dauvilliers Y; Dolenc-Groselj L; Lammers GJ; Mayer G; Pollmächer T; Reading P; Sonka K;
    Eur J Neurol; 2006 Oct; 13(10):1035-48. PubMed ID: 16987156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Pharmacotherapy Treatment on Patient-Reported Outcomes in a Narcolepsy and Idiopathic Hypersomnia Cohort.
    Pascoe M; Bena J; Foldvary-Schaefer N
    J Clin Sleep Med; 2019 Dec; 15(12):1799-1806. PubMed ID: 31855165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy.
    Weaver TE; Cuellar N
    Sleep; 2006 Sep; 29(9):1189-94. PubMed ID: 17040006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium oxybate and sleep apnea: a clinical case.
    Hartley S; Quera-Salva MA; Machou M
    J Clin Sleep Med; 2011 Dec; 7(6):667-8. PubMed ID: 22171208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.